Abstract
Development of the epicardium
The epicardium develops from the proepicardial organ located at the venous pole of the heart in continuity with the second heart field [1] . The epicardium is a mesothelial layer that forms a continuum with the coelomic lining and as such expresses many genes that are epithelial in origin like cytokeratin [2] and ␣4 integrin [3] . The evolutionary link to the developing excretory tract is exemplified by the expression of proteins like Wilms' tumour 1 (WT1) [4] and podoplanin [5, 6] . The guidance of the epicardium over the looping myocardial tube, which consists of both primary and second heart field derived myocardium [7] is still not completely understood, but epicardial-myocardial interaction including retinoic acid [4, 8] as well as members of the platelet-derived growth factor signalling are of relevance [9] .
Epithelial-mesenchymal transition into EPDCs
After initial spreading of the epicardium over the myocardium, several waves of epithelial-mesenchymal transition (EMT) have been described with subsequent migration into the sub-endocardial and intramyocardial location [10, 11] . The EPDCs that are essential for the isolation of atrial and ventricular myocardium, with the formation of the annulus fibrosis [12, 13] [19] , needs further research.
Derivatives of EPDCs

Potential role of EPDCs in cardiomyopathy and valve disease
The epicardium and EPDCs with their specific supporter role in myocardial differentiation and their homing to the fibrous annulus [12, 13] [1] but also in a far broader spectrum of cardiac diseases [20] .
Potential of EPDCs as adult stem cells
The convincingly proven essential functions of the epicardium and the EPDCs during normal embryonic development fuelled the hypothesis that EPDCs might recapitulate some of these functions in case of cardiac disease [21] . [24] . The combination worked synergistically, with these different cells having specific and separate functions. Altogether the conclusion was drawn that the observed effects were most probably based on paracrine or cell-cell interactions from the exogenous transplant with the surrounding host tissue [25] . [26] . (Fig. 1, compare control b1,2 (Fig. 1e-g ) with overlapping Katushka and WT1 staining (Fig. 1h) 
Reactivation of endogenous epicardium after ischemia
These findings triggered a new research field on EPDC-myocardial interaction. In the recent literature there are several reports on the activation of epicardium and the interstitial fibroblasts after myocardial infarction (MI) without additional stem cell transplantation. The group of Riley, for example, reported on the activation and coronary vascular improvement through thymosine B4
The factors triggering these events are not easily understood because of the concomitant effect of the influx of inflammatory cells after MI. We observed that 4 days after MI the endogenous epicardium and the interstitial fibroblasts started to re-express WT1
with 4 days after MI d1,2), an indication of activation and dedifferentiation. This was enhanced by 2 days if additionally exogenous EPDCs were injected (Fig. 1, compare medium injected c1,2 with EPDC injected c3,4 both 2 days after MI). To substantiate whether there was also renewed endogenous epicardial EMT and migration after ischemia, we injected a lentiviral Katushka construct (a far-red fluorescent marker) into the epicardial cavity of mice with or without MI. This showed indeed that re-activation of this embryonic program took place and that surface epicardial cells had migrated into the borderzone myocardium
